Carna Biosciences Inc
TSE:4572
Carna Biosciences Inc
Other Current Liabilities
Carna Biosciences Inc
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Carna Biosciences Inc
TSE:4572
|
Other Current Liabilities
¥248.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Other Current Liabilities
¥16.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Other Current Liabilities
¥15.3B
|
CAGR 3-Years
23%
|
CAGR 5-Years
20%
|
CAGR 10-Years
7%
|
Medinet Co Ltd
TSE:2370
|
Other Current Liabilities
¥147.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-4%
|
|
CellSource Co Ltd
TSE:4880
|
Other Current Liabilities
¥223.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Other Current Liabilities
¥5.6B
|
CAGR 3-Years
27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
41%
|
See Also
What is Carna Biosciences Inc's Other Current Liabilities?
Other Current Liabilities
248.2m
JPY
Based on the financial report for Dec 31, 2023, Carna Biosciences Inc's Other Current Liabilities amounts to 248.2m JPY.
What is Carna Biosciences Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
11%
Over the last year, the Other Current Liabilities growth was -12%. The average annual Other Current Liabilities growth rates for Carna Biosciences Inc have been -23% over the past three years , 8% over the past five years , and 11% over the past ten years .